2 results
Approved WMOCompleted
The objective of this trial is to demonstrate that bosentan delays disease worsening or death in patients with IPF.
Approved WMOCompleted
The primary objective of this study is to demonstrate that eritoran tetrasodium treatment of patients with severe sepsis results in a reduction in 28-day all-cause mortality.The secondary objectives are to confirm eritoran*s safety profile, and to…